Snapshot

DOI:

An expert review on managing cardiovascular masses using transcatheter vacuum-assisted aspiration; revascularisation vs medical therapy in 3-vessel disease; CT-μFR; follow-up after mitral transcatheter edge-to-edge repair; design of the DAPT-SHOCK-AMI trial; and more

From the aspiration of cardiovascular masses to new techniques for evaluating coronary lesions, or anatomical changes after mitral valve edge-to edge repair, a wide variety of topics are touched on in this issue – but what about that gorilla hiding in your cath lab? Do you know what that could be?

Transcatheter vacuum-assisted aspiration has become an alternative to surgery for certain high-risk patients with intracardiac and intravascular masses of various aetiologies, often seen as thrombi, tumours, or vegetations. In an expert review, Laura Besola, Andrea Colli and colleagues go over the current clinical evidence, indications and the different uses of vacuum-assisted aspiration in the treatment.

In a post hoc analysis of the ISCHEMIA trial, Sripal Bangalore, Judith S. Hochman and colleagues evaluate the outcomes of revascularisation versus medical therapy in patients with three-vessel coronary artery disease. Revascularisation, including both percutaneous coronary intervention and coronary artery bypass grafting, was associated with lower rates of cardiovascular death and myocardial infarction at four years, as well as an improved quality of life.

Tingwen Weng, Shengxian Tu and colleagues investigate the diagnostic performance of the Murray law-based quantitative flow ratio (CT-μFR), which is a novel coronary computed tomography angiography-derived method for quickly computing fractional flow reserve and identifying haemodynamically significant coronary stenoses and lesions.

Using transoesophageal echocardiography (TOE), Joanna Bartkowiak, Fabien Praz and colleagues evaluate anatomical changes and structural complications after mitral transcatheter edge-to-edge repair, investigating their association with clinical outcomes at two years.

Describing the upcoming DAPT-SHOCK-AMI trial, Zuzana Motovska, Deepak L. Bhatt and colleagues discuss the rationale and design of this study, which will randomise more than 500 patients to evaluate the benefits of cangrelor vs crushed ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock.

Volume 20 Number 20
Oct 21, 2024
Volume 20 Number 20
View full issue

Trending articles
225.68

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
105.78

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
77.85

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
68.7

Clinical research

10.4244/EIJ-D-21-00545 Sep 20, 2022
Coronary lithotripsy for the treatment of underexpanded stents: the international; multicentre CRUNCH registry
Tovar Forero M et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
45.3

Clinical research

10.4244/EIJ-D-18-01126 Aug 29, 2019
New-generation mechanical circulatory support during high-risk PCI: a cross-sectional analysis
Ameloot K et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved